Health Canada Approves OPDIVO® plus YERVOY® as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma Biotech Investing
AbbVie to Present Analysis Evaluating Continuous RINVOQ® Treatment in Psoriatic Arthritis for More Than One Year at EULAR 2021 Virtual Congress Biotech Investing
New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ® in Patients with Rheumatoid Arthritis to be Presented at EULAR 2021 Virtual Congress Biotech Investing
Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE Medical Device Investing
Bristol Myers Squibb Data at EULAR 2021 Highlight Commitment to Driving Advancements Across Multiple Immune-Mediated Rheumatic Diseases Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma Biotech Investing
Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month Medical Device Investing
Sanofi and Merck's first and only six-in-one pediatric combination vaccine now available in the United States Pharmaceutical Investing
Merck and Sanofi's First and Only Six-in-One Pediatric Combination Vaccine Now Available in the United States Pharmaceutical Investing
Avricore Health's HealthTab Signs Distribution Agreement to Expand Pharmacy Network and Test Offering Medical Device Investing
Jamieson Wellness Inc. Announces Voting Results from 2021 Annual and Special Meeting of Shareholders Pharmaceutical Investing
